Correspondence CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma Published April 10, 2024 N Engl J Med 2024;390: 1339 - 1341 DOI: 10.1056/NEJMc2213180 ...

Sven Jähnichen, Christophe Blanchetot, David Maussang, Maria Gonzalez-Pajuelo, Ken Y. Chow, Leontien Bosch, Sindi De Vrieze, Benedikte Serruys, Hans Ulrichts, Wesly Vandevelde, Michael Saunders, Hans ...

Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been ...

Product features Full-length CCR5 and CXCR4 proteins are with complete and native conformation Sophisticated immunogenicity due to inherent characteristics of VLP Excellent biological activity ...

However, other clinical applications for CXCR4 inhibitors in addition to anti-HIV therapy have been considered, as the interaction between CXCR4 and its ligand SDF-1 is also involved in several ...

CXCR4: A new drug target in lung cancer Date: May 1, 2010 Source: European Society for Medical Oncology Summary: Lung cancer patients whose tumors over-express a cell surface molecule called CXCR4 ...

Methods: Both primary colorectal tumors and liver metastatic tumors were obtained from 12 patients with colorectal liver metastasis. Expression levels of CXCR4 and SDF-1 were determined using RT-PCR.

Aberrant CXCR4/CXCL12 signaling is involved in many pathophysiological processes such as cancer and inflammatory diseases. A natural fragment of serum albumin, named EPI-X4, has previously been ...

PENTIXAPHARM Secures € 15 Million Series A Financing to Develop CXCR4-Targeted Theranostics Funding will be used for phase I / phase II trials of the lead program PentixaTher/ PentixaFor ...

Role of CXCR4 in HIV Infection and its Potential as a Therapeutic Target Tsutomu Murakami; Naoki Yamamoto Disclosures Future Microbiol. 2010;5 (7):1025-1039. 0 ...